Tempest Therapeutics (TPST) Institutional Ownership $6.31 -0.03 (-0.47%) Closing price 04:00 PM EasternExtended Trading$6.40 +0.09 (+1.43%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Tempest Therapeutics (NASDAQ:TPST)CurrentInstitutional OwnershipPercentage22.52%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$53.49MNumber ofInstitutional Sellers(last 12 months)0 Get TPST Insider Trade Alerts Want to know when executives and insiders are buying or selling Tempest Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TPST Institutional Buying and Selling by Quarter Tempest Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Millennium Management LLC189,506$158K0.0%N/A0.434% 2/14/2025Jane Street Group LLC493,094$411K0.0%N/A1.130% 2/14/2025Northern Trust Corp67,815$57K0.0%+233.2%0.155% 2/13/2025XTX Topco Ltd160,807$134K0.0%+570.3%0.368% 2/12/2025Geode Capital Management LLC354,276$296K0.0%+61.0%0.812% 2/12/2025Versant Venture Management LLC3,507,055$2.93M3.4%N/A8.036% 2/11/2025Virtu Financial LLC43,105$36K0.0%N/A0.099% 11/16/2024Geode Capital Management LLC220,067$308K0.0%+42.7%0.873% 11/15/2024XTX Topco Ltd23,989$34K0.0%N/A0.095% 11/5/2024Empower Advisory Group LLC35,000$49K0.0%N/A0.139% Get the Latest News and Ratings for TPST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tempest Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/29/2024Fullcircle Wealth LLC62,000$87K0.0%N/A0.279% 8/9/2024Dimensional Fund Advisors LP25,084$55K0.0%N/A0.113% 5/20/2024Virtu Financial LLC28,574$112K0.0%+69.2%0.129% 2/15/2024MayTech Global Investments LLC10,000$44K0.0%N/A0.052% 8/14/2023Rock Springs Capital Management LP536,214$681K0.0%-34.9%4.026% 8/11/2023Sectoral Asset Management Inc.219,394$279K0.0%N/A1.893% 2/14/2022Maven Securities LTD77,377$409K0.0%-39.0%1.120% 11/15/2021Franklin Resources Inc.15,240$221K0.0%N/A0.227% 11/12/2021Renaissance Technologies LLC34,104$493K0.0%+26.9%0.509% 11/9/2021BlackRock Inc.82,698$1.20M0.0%+1,581.2%1.234% 11/9/2021Monashee Investment Management LLC60,000$868K0.2%-47.2%0.896% 8/18/2021Ikarian Capital LLC89,865$1.01M0.1%N/A7.076% 8/17/2021Boothbay Fund Management LLC10,477$117K0.0%N/A0.825% 8/16/2021Maven Securities LTD106,628$1.20M0.0%N/A8.396% 8/13/2021Renaissance Technologies LLC26,867$300K0.0%N/A2.116% 8/13/2021Knott David M13,833$155K0.1%N/A1.089% 8/13/2021Vanguard Group Inc.61,150$683K0.0%N/A4.815% 8/13/2021FMR LLC647,898$7.24M0.0%N/A51.016% 8/12/2021Monashee Investment Management LLC113,644$1.27M0.2%N/A8.948% 5/19/2021Squarepoint Ops LLC84,879$102K0.0%N/A0.446% 5/17/2021Goldman Sachs Group Inc.20,883$25K0.0%-50.9%0.110% 5/14/2021Dimensional Fund Advisors LP51,219$61K0.0%+259.3%0.269% 5/13/2021Barclays PLC42,638$51K0.0%-90.8%0.224% 5/13/2021Renaissance Technologies LLC924,801$1.11M0.0%+66.0%4.856% (Data available from 1/1/2016 forward) TPST Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TPST shares? During the previous two years, 13 institutional investors and hedge funds held shares of Tempest Therapeutics. The most heavily invested institutionals were Versant Venture Management LLC ($2.93M), Rock Springs Capital Management LP ($681K), Jane Street Group LLC ($411K), Geode Capital Management LLC ($296K), Sectoral Asset Management Inc. ($279K), Millennium Management LLC ($158K), and XTX Topco Ltd ($134K).Learn more on Tempest Therapeutics' institutional investors. What percentage of Tempest Therapeutics' stock is owned by institutional investors? 22.52% of Tempest Therapeutics' stock is owned by institutional investors. Learn more on TPST's institutional investor holdings. Which institutional investors have been buying Tempest Therapeutics' stock? Of the 12 institutional investors that purchased Tempest Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Versant Venture Management LLC ($3.51M), Jane Street Group LLC ($493.09K), Sectoral Asset Management Inc. ($219.39K), Geode Capital Management LLC ($200.04K), Millennium Management LLC ($189.51K), XTX Topco Ltd ($160.81K), and Fullcircle Wealth LLC ($62K). How much institutional buying is happening at Tempest Therapeutics? Institutional investors have bought a total of 4,763,147 shares in the last 24 months. This purchase volume represents approximately $53.49M in transactions. Related Companies MGNX Major Shareholders ZNTL Major Shareholders OPTN Major Shareholders CTNM Major Shareholders CLYM Major Shareholders VXRT Major Shareholders BYSI Major Shareholders OCX Major Shareholders IPA Major Shareholders ABOS Major Shareholders This page (NASDAQ:TPST) was last updated on 7/22/2025 by MarketBeat.com Staff From Our PartnersTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBitcoin Beats Gold — But This Coin Could Beat Them BothBitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, ...Weiss Ratings | SponsoredTrump’s $100 Trillion Land Rush Is OnWhat Is "The US: IPO"? You won't hear this on CNBC... but the government may soon open up hundreds of trill...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tempest Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tempest Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
